NCT01751087 - Cervical Preparation Before Dilation and Evacuation | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

June 30, 2014

Conditions

Abortion, Induced

Interventions

OTHER

Mifepristone

oral mifepristone 200 mg on Day 1.

DRUG

misoprostol

buccal misoprostol 400 mcg on Day 2

DEVICE

Osmotic dilators

osmotic dilators on Day 1

OTHER

placebo

placebo for mifepristone, on day 1

OTHER

placebo

placebo for misoprostol, on day 2

Trial Locations (7)

10012

Planned Parenthood of New York City, New York

15213

Magee Women's Hospital, Pittsburgh

60630

Family Planning Associates, Chicago

94110

San Francisco General Hospital, San Francisco

97210

Lovejoy Surgical Center, Portland

02115

Brigham and Women's Hospital, Boston

02118

Boston Medical Center, Boston

All Listed Sponsors

collaborator

Society of Family Planning

OTHER

lead

Planned Parenthood League of Massachusetts

OTHER